Study of suspected Guillain-Barré syndrome cases
Part of Brain & nervous system, Immune system & allergy clinical trials.
This is an observational study that looks at people who were suspected to have Guillain-Barré syndrome and were cared for at University Hospital of Basel in the past. It does not test a new treatment—researchers review existing care to learn more about this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a suspected diagnosis of Guillain-Barré syndrome
- You were treated at University Hospital of Basel between Jan 1, 2005 and Feb 28, 2021
- You did not refuse the study consent in general
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the drug efgartigimod can help people with Guillain-Barré Syndrome (GBS). If you have had GBS symptoms for less than two weeks and your weakness is moderate to severe, this study may be an option.
This study interviews children who had Guillain-Barré syndrome (GBS) to understand their experiences after recovery. It may help doctors better support young patients with GBS.
This study uses a special light and sound imaging technique to see inflammation and damage in the nerves of people with Guillain-Barré syndrome or CIDP. It may help doctors better understand and monitor these conditions.
This study tests whether immunoadsorption works as well as plasma exchange to improve symptoms in people with Guillain-Barré syndrome. The goal is to find which treatment helps recovery and is safer for patients.
This study examines patients who came to the emergency department with sudden neurological symptoms like weakness, numbness, speech problems, dizziness, or seizures. Researchers will review medical records to better understand how these conditions are diagnosed and what happens to patients over time.
This study looks at adults who had a serious, long-lasting seizure emergency called status epilepticus. It aims to better understand what happened and may help improve care for similar patients in the future.
Hear when a new Guillain-Barre Syndrome (GBS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.